10% at Adarx Pharmaceuticals, Inc. Buys $27.2 million in Stock

Sr One Capital Management, LLC, who serves as 10% at Adarx Pharmaceuticals, Inc. (ADRX), purchased 1,600,000 shares of the company's stock, according to a disclosure filed with the U.S. Securities and Exchange Commission.

The transaction was executed at a price of $17.00 per share, for a total value of approximately $27.2 million.

Insider transactions of this kind are publicly disclosed through Form 4 filings with the SEC, which must generally be submitted within two business days of the trade date.

Insider buying is sometimes viewed by investors as a signal of confidence in a company's prospects, though a single transaction does not necessarily indicate a broader trend.